Molecules/MOSUNETUZUMAB

MOSUNETUZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2022

Mechanism of action: T cell surface glycoprotein CD3 binding agent

Molecular Formula

0.00

Molecular Weight

g/mol

BTCT-4465ABTCT4465ALunsumioMOSUNETUZUMABMOSUNETUZUMAB AXGBMOSUNETUZUMAB-AXGBRG-7828RG7828RG-7828 (ANTI-CD20 & CD3)RO-7030816RO7030816

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to MOSUNETUZUMAB

Loading drug network...